Clinical Trials Browser

Adenocarcinoma, Follicular × tremelimumab × 1 year × Clear all

NCT03753919 2026-03-11

DUTHY

Phase 2 Terminated

79 enrolled 25 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular